Trimethoprim-Sulfamethoxazole for Animals

Trimethoprim-Sulfamethoxazole

Trimethoprim–sulfamethoxazole is a potentiated sulfonamide antibacterial combining inhibitors of successive folate-pathway steps. It is used extra-label in veterinary patients for selected susceptible bacterial infections and some opportunistic infections. Its clinical spectrum includes susceptible staphylococci, Enterobacterales and Nocardia, with organism- and infection-site-specific activity.

Group

Potentiated sulfonamide antibacterial

Mechanism of Action

Sulfamethoxazole competes with para-aminobenzoic acid at microbial dihydropteroate synthase, reducing dihydrofolate formation. Trimethoprim inhibits dihydrofolate reductase and limits subsequent tetrahydrofolate production. Sequential blockade restricts nucleotide synthesis and can produce synergistic bactericidal activity. Susceptibility of both pathway steps and available drug exposure determine the effectiveness of the combination.

Dose Rates

Dogs

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15 mg/kgPOEvery 12 hCombined-total dose; typical initial courses in the source are 7-14 days, adjusted to infection and response.
Susceptible bacterial infection – alternative30 mg/kgPOEvery 12–24 hCombined-total dose; choose the interval for the specific infection rather than treating the interval range as interchangeable.
Toxoplasmosis30 mg/kgPOEvery 12 hCombined-total alternative regimen; source also lists 15 mg/kg every 12 hours for 28 days.
Toxoplasmosis – alternative15 mg/kgPOEvery 12 hUp to 28 days; Combined-total dose.
Chronic pyoderma30 mg/kgPOEvery 12 hUp to 42 days; Combined-total dose; courses 21-42 days.
Bacterial urinary tract infection30 mg/kgPOEvery 12 hCombined-total dose.
Systemic infection or bacteraemia30–45 mg/kgPOEvery 12 hUp to 5 days; Combined-total dose; course 3-5 days.
Coccidiosis30 mg/kgPOEvery 24 hUp to 10 days; Combined-total dose.
Pneumocystosis15 mg/kgPOEvery 8 hUp to 21 days; Combined-total dose.
Pneumocystosis30 mg/kgPOEvery 12 hUp to 21 days; Combined-total dose.

Cats

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15 mg/kgPOEvery 12 hCombined-total dose; typical initial courses in the source are 7-14 days, adjusted to infection and response.
Susceptible bacterial infection – alternative30 mg/kgPOEvery 12–24 hCombined-total dose; choose the interval for the specific infection rather than treating the interval range as interchangeable.
Toxoplasmosis30 mg/kgPOEvery 12 hCombined-total alternative regimen; source also lists 15 mg/kg every 12 hours for 28 days.
Toxoplasmosis – alternative15 mg/kgPOEvery 12 hUp to 28 days; Combined-total dose.

Ferrets

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection30 mg/kgPOEvery 12 hCombined-total dose.
Coccidiosis30 mg/kgPOEvery 24 hUp to 14 days; Combined-total dose.

Rabbits

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12–24 hCombined-total oral regimen.

Chinchillas

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Gerbils

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Guinea pigs

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Hamsters

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Mice

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Rats

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection15–30 mg/kgPOEvery 12 hCombined-total dose.

Horses

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection25–30 mg/kgPOEvery 12 hCombined-total dose. Oral sulfadiazine products have the stronger equine evidence; administer before hay where feasible.
Foal susceptible bacterial infection15 mg/kgPOEvery 12 hFoal alternative from the supplied formulary; combined-total dose.

Birds

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection50–100 mg/kgPOEvery 12 hCombined-total dose; psittacine regimens vary and macaws may vomit.
Coccidiosis105.6 mg/kgPOEvery 24 hUp to 5 days; Toucans and mynahs: conversion of 2.2 mL/kg of a 48 mg/mL combined-total suspension.

Indications

  • Treatment of susceptible urinary, respiratory, skin or soft-tissue bacterial infections in dogs, cats and other supported veterinary species.
  • Treatment of selected susceptible bacterial prostatitis in dogs.
  • Treatment of susceptible nocardiosis or other supported opportunistic bacterial infections.
  • Treatment of selected Pneumocystis pneumonia in dogs, with a limited veterinary clinical evidence base.
  • Selected multiagent treatment of canine neosporosis, with limited regimen-specific clinical evidence.

Contraindications

  • Sulfonamide hypersensitivity; marked hepatic damage or blood dyscrasias.
  • Use cautiously in renal disease, dehydration and pregnancy; Dobermans are particularly susceptible to immune-mediated reactions.

Interactions

  • Methotrexate or pyrimethamine increases antifolate toxicity risk.
  • Methenamine can promote urinary precipitation; warfarin effects may increase.
  • IV potentiated sulfonamides with detomidine in horses can cause cardiac arrhythmias.

Adverse effects

  • Keratoconjunctivitis sicca, hepatopathy, cytopenias, immune-mediated polyarthritis and skin reactions in dogs.
  • Vomiting, diarrhoea and reversible suppression of thyroid function; diarrhoea or colitis in horses.

Toxicity

Overdose can cause CNS signs, marrow suppression and urinary crystallisation. Provide hydration and supportive care; folinic acid may be needed for severe marrow toxicity.

Preparations

PreparationFormStrengthRoute
Co-trimoxazole 80/400 mg tablet
Strengths list trimethoprim/sulfamethoxazole separately; combined-total regimen. No single-component conversion selected.
Tablettrimethoprim 80 mg / tablet + sulfamethoxazole 400 mg / tabletPO
Co-trimoxazole 160/800 mg tablet
Strengths list trimethoprim/sulfamethoxazole separately; combined-total regimen. No single-component conversion selected.
Tablettrimethoprim 160 mg / tablet + sulfamethoxazole 800 mg / tabletPO
Co-trimoxazole oral suspension 40/200 mg per 5 mL
Combined total 240 mg per 5 mL.
Oral Liquidtrimethoprim 40 mg / 5 mL + sulfamethoxazole 200 mg / 5 mLPO
Co-trimoxazole IV concentrate 16/80 mg per mL
Dilute before IV infusion: source describes 5 mL in 75-125 mL D5W over 60 minutes; inspect for crystals. Stability depends on final dilution; do not refrigerate.
Injectiontrimethoprim 16 mg / mL + sulfamethoxazole 80 mg / mLIV

Monitoring and Administration

Monitor clinical response, hydration, CBC, hepatic/renal indices and tear production with prolonged treatment; thyroid tests can be reversibly depressed.

For a 1:5 trimethoprim:sulfonamide product, 30 mg/kg combined total equals 5 mg/kg trimethoprim plus 25 mg/kg sulfonamide. Never calculate the whole dose from trimethoprim concentration alone.

Oral trimethoprim absorption is poor in adult ruminants; calf data must not be generalized to adult cattle.

Multidrug protozoal regimens: canine Neospora protocols use combined TMP/sulfa 15 mg/kg PO every 12 hours for 4 weeks with clindamycin 10 mg/kg every 12 hours or pyrimethamine 1 mg/kg daily. Hepatozoon protocols use TMP/sulfa 15 mg/kg every 12 hours, pyrimethamine 0.25 mg/kg daily and clindamycin 10 mg/kg every 8 hours; courses differ by species and disease. These combinations require the complete protocol, not isolated single-drug arithmetic.

Scroll to Top